study of giving chemotherapy once every 3 weeks instead of once every 4 weeks along with chemotherapy to spinal fluid in retinoblastoma
Not Applicable
- Conditions
- Health Condition 1: null- INTERNATIONAL RETINOBLASTOMA STAGING SYSTEM (IRSS) STAGE III
- Registration Number
- CTRI/2012/01/002333
- Lead Sponsor
- ALL INDIA INSTITUTE OF MEDICAL SCIENCES AIIMS
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Open to Recruitment
- Sex
- Not specified
- Target Recruitment
- 60
Inclusion Criteria
Untreated consecutive IRSS stage III retinoblastoma patients will be included in the present study.
Exclusion Criteria
1.Metastatic disease at baseline
2.Relapsed retinoblastoma in the same eye
3.Received previous chemotherapy for retinoblastoma
4.Upfront enucleation or exenteration of the involved eye
5.Does not consent to participate in the study
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method